{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:30:02Z","timestamp":1788449402697,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institute of Health","award":["2025E110100"],"award-info":[{"award-number":["2025E110100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00467-025-06961-5","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T21:53:42Z","timestamp":1760478822000},"page":"529-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors influencing serum uric acid levels and their impact on cardiovascular risk in patients with pediatric chronic kidney disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Myung Hyun","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Gyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo Han","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eujin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Sun","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Il","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keum Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeyeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-5855","authenticated-orcid":false,"given":"Eun Mi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"6961_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3339\/ckd.24.016","volume":"28","author":"MH Cho","year":"2024","unstructured":"Cho MH (2024) Association between serum uric acid and kidney disease with pediatric focus. Child Kidney Dis 28:106\u2013111","journal-title":"Child Kidney Dis"},{"key":"6961_CR2","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.1038\/s41598-019-43241-3","volume":"9","author":"TR Oh","year":"2019","unstructured":"Oh TR, Choi HS, Kim CS, Bae EH, Ma SK, Sung SA, Kim YS, Oh KH, Ahn C, Kim SW (2019) Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study. Sci Rep 9:6681","journal-title":"Sci Rep"},{"key":"6961_CR3","doi-asserted-by":"crossref","unstructured":"Zhu P, Liu Y, Han L, Xu G, Ran JM (2014) Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies. PLoS One 9:e100801","DOI":"10.1371\/journal.pone.0100801"},{"key":"6961_CR4","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","volume":"382","author":"A Doria","year":"2020","unstructured":"Doria A, Galecki AT, Spino C, Pop-Busui R, Cherney DZ, Lingvay I, Parsa A, Rossing P, Sigal RJ, Afkarian M, Aronson R, Caramori ML, Crandall JP, de Boer IH, Elliott TG, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Maahs DM, McGill JB, Molitch ME, Perkins BA, Polsky S, Pragnell M, Robiner WN, Rosas SE, Senior P, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M (2020) Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med 382:2493\u20132503","journal-title":"N Engl J Med"},{"key":"6961_CR5","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","volume":"382","author":"SV Badve","year":"2020","unstructured":"Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, Clarke P, Dalbeth N, Day RO, de Zoysa JR, Douglas B, Faull R, Harris DC, Hawley CM, Jones GRD, Kanellis J, Palmer SC, Perkovic V, Rangan GK, Reidlinger D, Robison L, Walker RJ, Walters G, Johnson DW (2020) Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med 382:2504\u20132513","journal-title":"N Engl J Med"},{"key":"6961_CR6","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) Kdigo 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105:S117\u2013S314","journal-title":"Kidney Int"},{"key":"6961_CR7","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.amjcard.2017.06.057","volume":"120","author":"A Palazzuoli","year":"2017","unstructured":"Palazzuoli A, Ruocco G, De Vivo O, Nuti R, McCullough PA (2017) Prevalence of hyperuricemia in patients with acute heart failure with either reduced or preserved ejection fraction. Am J Cardiol 120:1146\u20131150","journal-title":"Am J Cardiol"},{"key":"6961_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.14740\/jocmr4171","volume":"12","author":"I Miyabayashi","year":"2020","unstructured":"Miyabayashi I, Mori S, Satoh A, Kawazoe M, Funakoshi S, Ishida S, Maeda T, Yoshimura C, Tada K, Takahashi K, Ito K, Yasuno T, Masutani K, Kondo S, Nakashima H, Arima H (2020) Uric acid and prevalence of hypertension in a general population of Japanese: ISSA-CKD study. J Clin Med Res 12:431\u2013435","journal-title":"J Clin Med Res"},{"key":"6961_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1161\/01.STR.0000081983.34771.D2","volume":"34","author":"CJ Weir","year":"2003","unstructured":"Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34:1951\u20131956","journal-title":"Stroke"},{"key":"6961_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382:339\u2013352","journal-title":"Lancet"},{"key":"6961_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12882-018-1143-7","volume":"20","author":"Q Luo","year":"2019","unstructured":"Luo Q, Xia X, Li B, Lin Z, Yu X, Huang F (2019) Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis. BMC Nephrol 20:18","journal-title":"BMC Nephrol"},{"key":"6961_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12882-016-0248-0","volume":"17","author":"HG Kang","year":"2016","unstructured":"Kang HG, Choi HJ, Han KH, Kim SH, Cho HY, Cho MH, Shin JI, Lee JH, Lee J, Oh KH, Park YS, Cheong HI, Ahn C, Ha IS (2016) KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): design and methods. BMC Nephrol 17:35","journal-title":"BMC Nephrol"},{"key":"6961_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ki.2012.169","volume":"82","author":"GJ Schwartz","year":"2012","unstructured":"Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA, Furth SL, Mu\u00f1oz A (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82:445\u2013453","journal-title":"Kidney Int"},{"key":"6961_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"6961_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1053\/j.ajkd.2015.01.008","volume":"65","author":"BA Warady","year":"2015","unstructured":"Warady BA, Abraham AG, Schwartz GJ, Wong CS, Mu\u00f1oz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S (2015) Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the chronic kidney disease in children (CKiD) cohort. Am J Kidney Dis 65:878\u2013888","journal-title":"Am J Kidney Dis"},{"key":"6961_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3345\/kjp.2018.61.5.135","volume":"61","author":"JH Kim","year":"2018","unstructured":"Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, Lee JH, Kim SC, Lim D, Yang SW, Oh K, Moon JS (2018) The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr 61:135\u2013149","journal-title":"Korean J Pediatr"},{"key":"6961_CR17","first-page":"998","volume":"51","author":"JA Sohn","year":"2008","unstructured":"Sohn JA, Lee HS, Lim KA, Yoon SY, Jung JW, Kim NS, Noh CI, Lee SY, Hong YM (2008) Normal blood pressure values and percentile curves measured by oscillometric method in children under 6 years of age. Clin Exp Pediatr 51:998\u20131006","journal-title":"Clin Exp Pediatr"},{"key":"6961_CR18","first-page":"33","volume":"51","author":"CG Lee","year":"2008","unstructured":"Lee CG, Moon JS, Choi J-M, Nam CM, Lee SY, Oh K, Kim YT (2008) Normative blood pressure references for Korean children and adolescents. Clin Exp Pediatr 51:33\u201341","journal-title":"Clin Exp Pediatr"},{"key":"6961_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613\u2013618","journal-title":"Circulation"},{"key":"6961_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.2005030276","volume":"17","author":"MC Matteucci","year":"2006","unstructured":"Matteucci MC, W\u00fchl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F (2006) Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17:218\u2013226","journal-title":"J Am Soc Nephrol"},{"key":"6961_CR21","doi-asserted-by":"publisher","unstructured":"Song JY, Lee KH, Shin JI, Kang HG, Ahn YH, Baek HS, Cho MH, Jung J, Lee JH, Cho H, Han KH, Park E, Yang EM, Kim SH (2024) Baseline characteristics and associated factors for hypertension in children with chronic kidney disease: results from the Korean Cohort Study for Outcome in Patients with Pediatric Chronic Kidney Disease study. Kidney Res Clin Pract. https:\/\/doi.org\/10.23876\/j.krcp.24.006","DOI":"10.23876\/j.krcp.24.006"},{"key":"6961_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000478867","volume":"42","author":"H Cho","year":"2017","unstructured":"Cho H, Choi HJ, Kang HG, Ha IS, Cheong HI, Han KH, Kim SH, Cho MH, Shin JI, Lee JH, Park YS (2017) Influence of the method of definition on the prevalence of left-ventricular hypertrophy in children with chronic kidney disease: data from the know-Ped CKD study. Kidney Blood Press Res 42:406\u2013415","journal-title":"Kidney Blood Press Res"},{"key":"6961_CR23","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1053\/j.ajkd.2015.06.015","volume":"66","author":"KE Rodenbach","year":"2015","unstructured":"Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, Warady BA, Schwartz GJ (2015) Hyperuricemia and progression of CKD in children and adolescents: the chronic kidney disease in children (CKiD) cohort study. Am J Kidney Dis 66:984\u2013992","journal-title":"Am J Kidney Dis"},{"key":"6961_CR24","first-page":"6","volume":"9","author":"J Xu","year":"2021","unstructured":"Xu J, Tong L, Mao J (2021) Hyperuricemia and associated factors in children with chronic kidney disease: a cross-sectional study. Children (Basel) 9:6","journal-title":"Children (Basel)"},{"key":"6961_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0022-3476(96)70322-0","volume":"128","author":"WD Wilcox","year":"1996","unstructured":"Wilcox WD (1996) Abnormal serum uric acid levels in children. J Pediatr 128:731\u2013741","journal-title":"J Pediatr"},{"key":"6961_CR26","doi-asserted-by":"publisher","first-page":"1159248","DOI":"10.3389\/fendo.2023.1159248","volume":"14","author":"YJ Seo","year":"2023","unstructured":"Seo YJ, Shim YS, Lee HS, Hwang JS (2023) Association of serum uric acid levels with metabolic syndromes in Korean adolescents. Front Endocrinol (Lausanne) 14:1159248","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6961_CR27","doi-asserted-by":"publisher","first-page":"e15611","DOI":"10.1097\/MD.0000000000015611","volume":"98","author":"Z Liu","year":"2019","unstructured":"Liu Z, Ding X, Wu J, He H, Wu Z, Xie D, Yang Z, Wang Y, Tian J (2019) Dose-response relationship between higher serum calcium level and higher prevalence of hyperuricemia: a cross-sectional study. Medicine (Baltimore) 98:e15611","journal-title":"Medicine (Baltimore)"},{"key":"6961_CR28","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/ar3769","volume":"14","author":"JY Hui","year":"2012","unstructured":"Hui JY, Choi JW, Mount DB, Zhu Y, Zhang Y, Choi HK (2012) The independent association between parathyroid hormone levels and hyperuricemia: a national population study. Arthritis Res Ther 14:R56","journal-title":"Arthritis Res Ther"},{"key":"6961_CR29","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s11255-022-03116-5","volume":"54","author":"TEM Costa","year":"2022","unstructured":"Costa TEM, Lauar JC, Innecchi MLR, Coelho VA, Moys\u00e9s RMA, Elias RM (2022) Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease. Int Urol Nephrol 54:2255\u20132261","journal-title":"Int Urol Nephrol"},{"key":"6961_CR30","doi-asserted-by":"publisher","first-page":"994979","DOI":"10.3389\/fped.2023.994979","volume":"11","author":"J Jung","year":"2023","unstructured":"Jung J, Lee KH, Park E, Park YS, Kang HG, Ahn YH, Ha IS, Kim SH, Cho H, Han KH, Cho MH, Choi HJ, Lee JH, Shin JI (2023) Mineral bone disorder in children with chronic kidney disease: data from the KNOW-Ped CKD (korean cohort study for outcome in patients with pediatric chronic kidney disease) study. Front Pediatr 11:994979","journal-title":"Front Pediatr"},{"key":"6961_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/08037050903244783","volume":"18","author":"ZS Lu","year":"2009","unstructured":"Lu ZS, Lu ZH, Lu H, Yan SG, Wang JA, Li L, You W (2009) Association between hyperuricemia and hypertension in a Chinese population at a high risk of hypertension. Blood Press 18:268\u2013272","journal-title":"Blood Press"},{"key":"6961_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpeds.2012.06.008","volume":"162","author":"DG Noone","year":"2013","unstructured":"Noone DG, Marks SD (2013) Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. J Pediatr 162:128\u2013132","journal-title":"J Pediatr"},{"key":"6961_CR33","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3346\/jkms.2014.29.8.1077","volume":"29","author":"HA Kim","year":"2014","unstructured":"Kim HA, Seo YI, Song YW (2014) Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men. J Korean Med Sci 29:1077\u20131081","journal-title":"J Korean Med Sci"},{"key":"6961_CR34","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2215\/CJN.11451210","volume":"6","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ (2011) A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 6:1887\u20131894","journal-title":"Clin J Am Soc Nephrol"},{"key":"6961_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3109\/08037051.2010.532323","volume":"20","author":"K Kostka-Jeziorny","year":"2011","unstructured":"Kostka-Jeziorny K, Uruski P, Tykarski A (2011) Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients. Blood Press 20:104\u2013110","journal-title":"Blood Press"},{"key":"6961_CR36","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1681\/ASN.2016050521","volume":"28","author":"DI Jalal","year":"2017","unstructured":"Jalal DI, Decker E, Perrenoud L, Nowak KL, Bispham N, Mehta T, Smits G, You Z, Seals D, Chonchol M, Johnson RJ (2017) Vascular function and uric acid-lowering in stage 3 CKD. J Am Soc Nephrol 28:943\u2013952","journal-title":"J Am Soc Nephrol"},{"key":"6961_CR37","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"DI Feig","year":"2008","unstructured":"Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300:924\u2013932","journal-title":"JAMA"},{"key":"6961_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40620-013-0009-0","volume":"27","author":"F Assadi","year":"2014","unstructured":"Assadi F (2014) Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension. J Nephrol 27:51\u201356","journal-title":"J Nephrol"},{"key":"6961_CR39","first-page":"e43361","volume":"15","author":"TJ Ubhadiya","year":"2023","unstructured":"Ubhadiya TJ, Dubey N, Sojitra MH, Shah K, Joshi S, Gandhi SK, Patel P (2023) Exploring the effects of elevated serum uric acid levels on hypertension: a scoping review of hyperuricemia. Cureus 15:e43361","journal-title":"Cureus"},{"key":"6961_CR40","doi-asserted-by":"publisher","first-page":"570000","DOI":"10.3389\/fcvm.2020.570000","volume":"7","author":"V Visco","year":"2020","unstructured":"Visco V, Pascale AV, Virtuoso N, Mongiello F, Cinque F, Gioia R, Finelli R, Mazzeo P, Manzi MV, Morisco C, Rozza F, Izzo R, Cerasuolo F, Ciccarelli M, Iaccarino G (2020) Serum uric acid and left ventricular mass in essential hypertension. Front Cardiovasc Med 7:570000","journal-title":"Front Cardiovasc Med"},{"key":"6961_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1399-0012.2010.01244.x","volume":"25","author":"Y Caliskan","year":"2011","unstructured":"Caliskan Y, Gorgulu N, Yelken B, Akturk F, Yazici H, Turkmen A, Sever MS (2011) Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients. Clin Transplant 25:368\u2013374","journal-title":"Clin Transplant"},{"key":"6961_CR42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.numecd.2016.03.011","volume":"26","author":"WY Liang","year":"2016","unstructured":"Liang WY, Liu WW, Liu ML, Xiang W, Feng XR, Huang B, Chen XH, Sun YS (2016) Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation. Nutr Metab Cardiovasc Dis 26:575\u2013580","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"6961_CR43","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","volume":"36","author":"P Verdecchia","year":"2000","unstructured":"Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36:1072\u20131078","journal-title":"Hypertension"},{"key":"6961_CR44","doi-asserted-by":"publisher","first-page":"e007523","DOI":"10.1161\/JAHA.117.007523","volume":"7","author":"WC Tseng","year":"2018","unstructured":"Tseng WC, Chen YT, Ou SM, Shih CJ, Tarng DC (2018) U-shaped association between serum uric acid levels with cardiovascular and all-cause mortality in the elderly: the role of malnourishment. J Am Heart Assoc 7:e007523","journal-title":"J Am Heart Assoc"},{"key":"6961_CR45","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.40472","volume":"70","author":"SK Cho","year":"2018","unstructured":"Cho SK, Chang Y, Kim I, Ryu S (2018) U-shaped association between serum uric acid level and risk of mortality: a cohort study. Arthritis Rheumatol 70:1122\u20131132","journal-title":"Arthritis Rheumatol"},{"key":"6961_CR46","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3390\/jcm9072027","volume":"9","author":"S Masi","year":"2020","unstructured":"Masi S, Georgiopoulos G, Alexopoulos G, Pateras K, Rosada J, Seravalle G, De Ciuceis C, Taddei S, Borghi C, Grassi G, Rizzoni D, Virdis A, The Study Groups On The Uric Acid Right For heArt Health Urrah, Micro-And Macro-Circulation Of The Italian Society Of Hypertension Siia (2020) The complex relationship between serum uric acid, endothelial function and small vessel remodeling in humans. J Clin Med 9:2027","journal-title":"J Clin Med"},{"key":"6961_CR47","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78:6858\u20136862","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6961_CR48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1475-2840-12-159","volume":"12","author":"Y Nishida","year":"2013","unstructured":"Nishida Y, Takahashi Y, Susa N, Kanou N, Nakayama T, Asai S (2013) Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study. Cardiovasc Diabetol 12:159","journal-title":"Cardiovasc Diabetol"},{"key":"6961_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/hr.2014.161","volume":"38","author":"K Nagahama","year":"2015","unstructured":"Nagahama K, Inoue T, Kohagura K, Kinjo K, Ohya Y (2015) Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens Res 38:213\u2013218","journal-title":"Hypertens Res"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06961-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06961-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06961-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:02:37Z","timestamp":1766523757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06961-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6961"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06961-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures and declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}